Challenges in drug development for central nervous system disorders: a European Medicines Agency perspective
2016 ◽
Vol 15
(12)
◽
pp. 813-814
◽
2012 ◽
Vol 12
(9)
◽
pp. 1033-1071
◽
2004 ◽
2018 ◽
Vol 66
(1)
◽
pp. e25